Clinica Chimica Acta, Год журнала: 2025, Номер 571, С. 120243 - 120243
Опубликована: Март 14, 2025
Язык: Английский
Clinica Chimica Acta, Год журнала: 2025, Номер 571, С. 120243 - 120243
Опубликована: Март 14, 2025
Язык: Английский
International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(4), С. 1621 - 1621
Опубликована: Фев. 14, 2025
Tuberculosis (TB) remains one of the most challenging infectious diseases, with Mycobacterium tuberculosis (Mtb) employing sophisticated mechanisms to evade host immunity and establish persistent infections. This review explores recent advances in understanding Mtb's immune evasion strategies; granuloma dynamics; emerging immunotherapeutic approaches. Key findings highlight manipulation autophagy; metabolic reprogramming; cytokine pathways by Mtb sustain its survival within cells. Insights into formation reveal critical role bacterial lipids; modulation; hypoxia-driven dormancy maintaining chronic infection. Innovative therapeutic strategies, including host-directed therapies; epigenetic interventions; immunomodulators, hold promise for improving TB management combating drug-resistant strains. Despite these advancements, significant challenges remain, development effective vaccines; addressing latent TB; ensuring equitable access novel treatments. The integration advanced technologies such as artificial intelligence multi-omics approaches, alongside global collaboration, is essential overcome hurdles. underscores importance a multidisciplinary approach tackling TB, ultimate goal eradicating this health threat.
Язык: Английский
Процитировано
1Clinical Reviews in Allergy & Immunology, Год журнала: 2025, Номер 68(1)
Опубликована: Фев. 20, 2025
Язык: Английский
Процитировано
0Clinica Chimica Acta, Год журнала: 2025, Номер 571, С. 120243 - 120243
Опубликована: Март 14, 2025
Язык: Английский
Процитировано
0